Blood Cancer Talks

Rajshekhar Chakraborty, Ashwin Kishtagari, and Edward Cliff
undefined
Aug 24, 2022 • 1h 3min

Episode 4. Measurable Residual Disease in AML

2021 European LeukemiaNET MRD Working Party Consensus Guidelines: https://pubmed.ncbi.nlm.nih.gov/34724563/Pre-MEASURE Study ASCO 2022: https://ascopubs.org/doi/abs/10.1200/JCO.2022.40.16_suppl.7006
undefined
5 snips
Aug 10, 2022 • 46min

Episode 3. Management of Waldenström Macroglobulinemia

https://ascopubs.org/doi/abs/10.1200/JCO.22.00495
undefined
Jul 27, 2022 • 32min

Episode 2. CAR T-Cell Therapy in Multiple Myeloma

In this episode, we discuss with Dr. Surbhi Sidana the latest advances, practical aspects of patient management, and future directions of cellular therapies in multiple myeloma.
undefined
Jul 15, 2022 • 51min

Episode 1. Implications of Clonal Hematopoiesis

In this episode, we bring two experts in clonal hematopoiesis, Dr. Sid Jaiswal from Stanford University and Dr. Alex Bick from Vanderbilt University to dissect the biology, potential clinical implications, and future of clonal hematopoiesis.
undefined
Jul 8, 2022 • 2min

Introduction to BloodCancerTalks

BloodCancerTalks is a new podcast focusing exclusively on hematologic malignancies. We will bring a wide range of experts to dig deep into specific topics and critically appraise the literature. Raj Chakraborty is a hematologist/oncologist and an Assistant Professor of Medicine at Columbia University. Ash Kishtagari is a hematologist/oncologist and an Assistant Professor of Medicine at Vanderbilt University.

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app